FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for RETROVIR (zidovudine) filed by ViiV Healthcare, indicating an update to the drug's labeling and approved uses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• RETROVIR (Zidovudine)

Snippet

SUPPL AP for RETROVIR (ZIDOVUDINE)